Early dexamethasone - Attempting to prevent chronic lung disease

Pediatrics

Volumn 105, Issue 3, 2000, Pages 542-548

  Sinkin, Robert A ^a,e   Dweck, Harry S ^b   Horgan, Michael J ^c   Gallaher, Keith J ^d   Cox, Christopher ^a   Maniscalco, William M ^a   Chess, Patricia R ^a   D'Angio, Carl T ^a   Guillet, Ronnie ^a   Kendig, James W ^a   Ryan, Rita M ^a   Phelps, Dale L ^a  

^a Golisano Childrens Hospital at Strong   (United States)

^b WESTCHESTER MEDICAL CENTER   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

^d Cape Fear Valley Medical Center   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Bronchopulmonary dysplasia; Glucocorticoids; Neonate; Randomized clinical trials; Respiratory distress syndrome

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; LUNG SURFACTANT; PLACEBO; SODIUM CHLORIDE;

ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; BLOOD PRESSURE; BRAIN HEMORRHAGE; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HUMAN; INTESTINE PERFORATION; LENGTH OF STAY; LUNG DYSPLASIA; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NECROTIZING ENTEROCOLITIS; NEWBORN; OXYGEN THERAPY; PNEUMOTHORAX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; RETROLENTAL FIBROPLASIA; SURVIVAL RATE;

EID: 0034094809     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.105.3.542     Document Type: Article

References (56)

1. Sanders RJ, Cox C, Phelps DL, Sinkin RA. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr Res. 1994;36: 122-128
2. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Engl J Med. 1967;276:357-368
3. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics. 1996;97:210-215
4. Bagchi A, Viscardi RM, Taciak V, Ensor JE, McCrea KA, Hasday JD. Increased activity of interleukin-6 but not tumor necrosis factor-alpha in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia. Pediatr Res. 1994;36:244-252
5. Doshi N, Kanbour A, Fujikura T, Klionsky B. Tracheal aspiration cytology in neonates with respiratory distress: histopathologic correlation. Acta Cytol. 1982;26:15-21
6. LoMonaco MB, Barber CM, Sinkin RA. Differential cytokine mRNA expression by neonatal pulmonary cells. Pediatr Res. 1996;39:248-252
7. Merritt TA, Puccia JM, Stuard ID. Cytologic evaluation of pulmonary effluent in neonates with respiratory distress syndrome and broncho-pulmonary dysplasia. Acta Cytol. 1981;25:631-639
8. Merritt TA, Stuard ID, Puccia J, et al. Newborn tracheal aspirate cytology: classification during respiratory distress syndrome and bronchopulmonary dysplasia. J Pediatr. 1981;98:949-956
9. Ogden BE, Murphy S, Saunders GC, Johnson JD. Lung lavage of newborns with respiratory distress syndrome: prolonged neutrophil influx is associated with bronchopulmonary dysplasia. Chest. 1983;83:31S-33S
10. Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis. 1984;130:817-821
11. Avery GB, Fletcher AB, Kaplan M, Brudno DS. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics. 1985;75:106-111
12. Cummings JJ, D'Eugenio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med. 1989;320:1505-1510
13. Brozanski BS, Jones JG, Gilmour CH, et al. Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant. J Pediatr. 1995;126:769-776
14. Mammel MC, Green TP, Johnson DE, Thompson TR. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet. 1983;1:1356-1358
15. Mammel MC, Fiterman C, Coleman M, Boros SJ. Short-term dexamethasone therapy for bronchopulmonary dysplasia: acute effects and 1-year follow-up. Dev Pharm Ther. 1987;10:1-11
16. Kothadia JM, O'Shea TM, Roberts D, Auringer ST, Weaver RG, Dillard I. Randomized placebo-controlled trial of a 42-Day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants. Pediatrics. 1999;104:22-27
17. Bourchier D. Dexamethasone therapy in severe bronchopulmonary dysplasia. Aunt Paediatr J. 1988;24:41-44
18. Rastogi A, Akintorin SM, Bez ML, Morales P, Pildes RS. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Pediatrics. 1996;98:204-210
19. Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J Pediatr. 1990;117: 273-282
20. Yeh TF. Is chronic lung disease (CLD) in premature infants preventable? Acta Paediatr Sinica. 1996;37:241-243
21. Cole CH, Colton T, Shah BL, et al. Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia. N Engl J Med. 1999;340: 1005-1010
22. Garland JS, Alex CP, Pauly TH, et al. A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial. Pediatrics. 1999;104:91-99
23. Kovacs L, Davis GM, Faucher D, Papageorgiou A. Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity. Acta Paediatr. 1998;87:792-798
24. Co E, Chari G, McCulloch K, Vidyasagar D. Dexamethasone treatment suppresses collagen synthesis in infants with bronchopulmonary dysplasia. Pediatr Pulmonol. 1993;16:36-40
25. Greenough A, Emery EF, Gamsu HR. Dexamethasone and hypertension in preterm infants. Eur J Pediatr. 1992;151:134-135
26. Ng PC, Brownlee KG, Dear PR. Gastroduodenal perforation in preterm babies treated with dexamethasone for bronchopulmonary dysplasia. Arch Dis Child. 1991;66:1164-1166
27. O'Neil EA, Chwals WJ, O'Shea MD, Turner CS. Dexamethasone treatment during ventilator dependency: possible life threatening gastrointestinal complications. Arch Dis Child. 1992;67:10-11
28. Van Goudoever JB, Wattimena JD, Carnielli VP, Sulkers EJ, Degenhart HJ, Sauer PJ. Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia. J Pediatr. 1994;124:112-118
29. Werner JC, Sicard RE, Hansen TW, Solomon E, Cowett RM, Oh W. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary. J Pediatr. 1992;120:286-291
30. Kendig JW, Ryan RM, Sinkin RA, et al. Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial. Pediatrics. 1998;101:1006-1012
31. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988;82:527-532
32. Noble-Jamieson CM, Regev R, Silverman M. Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications. Eur J Pediatr. 1989;148:365-367
33. Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics. 1991;88:421-427
34. Avery ME, Merritt TA. Surfactant-replacement therapy. N Engl J Med. 1991;324:910-912
35. Harkavy KL, Scanlon JW, Chowdhry PK, Grylack LJ. Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: a controlled trial. J Pediatr. 1989;115:979-983
36. Kazzi NJ, Brans YW, Poland RL. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Pediatrics. 1990;86:722-727
37. Papile LA, Tyson JE, Stoll BJ, et al. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. N Engl J Med. 1998;338:1112-1118
38. Durand M, Sardesai S, McEvoy C. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial. Pediatrics. 1995;95: 584-590
39. Kari MA, Heinonen K, Ikonen RS, Koivisto M, Raivio KO. Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia. Arch Dis Child. 1993;68:566-569
40. Tapia JL, Ramirez R, Cifuentes J, et al. The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome. J Pediatr. 1998;132:48-52
41. Morris HG. Mechanisms of glucocorticoid action in pulmonary disease. Chest. 1985;88:133S-141S
42. Shinwell ES, Karplus M, Zmora E, et al. Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed. 1996;74:F33-37
43. Wang JY, Yeh TF, Lin YJ, Chen WY, Lin CH. Early postnatal dexamethasone therapy may lessen lung inflammation in premature infants with respiratory distress syndrome on mechanical ventilation. Pediatr Pulmonol. 1997;23:193-197
44. Watts CL, Bruce MC Effect of dexamethasone therapy on fibronectin and albumin levels in lung secretions of infants with bronchopulmonary dysplasia. J Pediatr. 1992;121:597-607
45. Yeh TF, Lin YJ, Hsieh WS, et al. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial. Pediatrics. 1997;100(4). URL: http://www.pediatrics.org/cgi/content/full/100/ 4/e3
46. Gerdes JS, Harris MC, Polin RA. Effects of dexamethasone and indomethacin on elastase, α 1-proteinase inhibitor, and fibronectin in bronchoalveolar lavage fluid from neonates. J Pediatr. 1988;113:727-731
47. Rindfleisch MS, Hasday JD, Taciak V, Broderick K, Viscardi RM. Potential role of interleukin-1 in the development of bronchopulmonary dysplasia. J Interferon Cytokine Res. 1996;16:365-373
48. Yoder MC, Jr., Chua R, Tepper R. Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia. Am Rev Respir Dis. 1991;143: 1044-1048
49. Watterberg KL, Scott SM. Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia. Pediatrics. 1995;95: 120-125
50. Cole CH, Frantz ID III. Role of postnatal steroids for neonatal chronic lung disease. In: Hansen TN, McIntosh N, eds. Current Topics in Neonatology, II. London, UK: WB Saunders Co; 1997:256-280
51. Knoppert DC, Mackanjee HR. Current strategies in the management of bronchopulmonary dysplasia: the role of corticosteroids. Neonatal Network, 1994;13:53-60
52. Bhuta T, Ohlsson A. Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease. Arch Dis Child Fetal Neonatal Ed. 1998;79:F26-33
53. Halliday HL, Ehrenkranz RA. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database of Systematic Review. 1999;2
54. Yeh TF, Lin YJ, Huang CC, et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics. 1998;101(5). URL: http:// www.pediatrics.org/cgi/content/full/101/5/e7
55. Gilmour CH, Sentipal-Walerius JM, Jones JG, et al. Pulse dexamethasone does not impair growth and body composition of very low birth weight infants. J Am Coll Nutr. 1995;14:455-462
56. O'Shea TM, Kothadia JM, Klinepeter KL, et al. Randomized placebo-controlled trial of a 42-Day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics. 1999; 104:15-21